Bio-Techne Introduces Advanced Designer Proteins
Bio-Techne (NASDAQ: TECH), a leader in life science tools and reagents, is excited to announce the launch of its enhanced portfolio of designer proteins, engineered through state-of-the-art Artificial Intelligence (AI) design platforms. This innovative approach not only reflects Bio-Techne's commitment to advancing cell therapy but also aims to revolutionize regenerative medicine.
Overview of the New Portfolio
The newly launched designer proteins include a variety of exciting additions such as the IL-2 Heat Stable Agonist and Activin A Hyperactive. This new range, from Bio-Techne's R&D Systems brand, also features FGF basic Heat Stable, engineered for performance in therapeutic development. They are produced under stringent good manufacturing processes (GMP), and are also available for research use only (RUO).
Innovation Through AI
These recombinant proteins are a breakthrough in the field of cellular therapy. Bio-Techne has leveraged nearly five decades of prowess in proteomics to train generative AI, crafting proteins with tailored functionalities. This innovative approach means these proteins exhibit extraordinary characteristics such as hyperactivity and enhanced receptor affinities, which are crucial in cell expansion and overall cell culture performance.
Key Features of the Designer Proteins
The new designer proteins boast several semantically significant attributes that cater to the needs of researchers and clinicians:
- IL-2 Heat Stable Agonist: This protein has been engineered for enhanced thermal stability, allowing for improved biological activity. It is well-suited for applications within cellular therapy, particularly for CAR T-cell and Tumor-infiltrating lymphocyte (TIL) expansion.
- Activin A Hyperactive: Optimized for superior functionality in regenerative medicine, this protein plays a crucial role in enhancing cell differentiation.
- FGF basic Heat Stable: A versatile growth factor, it ensures improved protein stability for stem cell culture and is available in both RUO and GMP formats, supporting advanced research and cell therapy manufacturing.
- Wnt/RSPO Agonists: The series of Wnt/RSPO proteins (Wnt/RSPO1, Wnt/RSPO2, and Wnt/RSPO3) are incredibly important reagents, pushing forward research in stem cell applications, organoid development, and regenerative medicine.
Empowering Research and Innovation
This expanded product line underscores Bio-Techne's dedication to driving innovation in the life sciences industry. As a valuable asset to therapeutic development communities, these AI-engineered designer proteins are set to enhance research workflows and reinforce the production of immune cells, furthering advancements in cell therapies.
The Impact on Clinical Applications
With the increasing complexity surrounding cell therapy, having access to these cutting-edge designer proteins will significantly aid scientists and clinicians. By utilizing advanced technology to refine reagents, Bio-Techne empowers its customers with high-performance solutions, ultimately enhancing the effectiveness and efficiency of therapeutic practices in both clinical and research environments.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) operates as a forefront entity in life sciences, providing revolutionary tools and bioactive reagents tailored for research and clinical diagnostics. Its extensive array of products supports scientific endeavors that delve into biological mechanisms and disease progression while facilitating drug discovery and clinical testing accuracy.
In the recent fiscal year, Bio-Techne celebrated approximately $1.2 billion in net sales and continues to employ over 3,100 dedicated professionals globally. Their commitment to improving life through science is evident in their portfolio, which encompasses hundreds of thousands of products.
Frequently Asked Questions
What are Bio-Techne's new designer proteins used for?
The new designer proteins are designed to enhance cell therapy workflows and improve regenerative medicine through optimized cell expansion and culture performance.
How does AI contribute to these new products?
AI technology is used to engineer these proteins, allowing for tailored functionalities such as hyperactivity and enhanced receptor affinities, improving their effectiveness in various applications.
In what formats are the proteins available?
The proteins are available in both research use only (RUO) formats and good manufacturing processes (GMP) formats for therapeutic development.
Who is Bio-Techne?
Bio-Techne is a global leader in life sciences tools and bioactive reagents, focused on helping researchers and clinicians advance biological discoveries and therapeutic developments.
What industries benefit from Bio-Techne's innovations?
Bio-Techne's products are utilized in various sectors, primarily in life sciences, clinical diagnostics, and therapeutic development, supporting advancements in research and patient care.
